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406-7	 How	Long	Does	Sympathetic	Activation	Persist	After	
Submaximal	Exercise	in	Subjects	with	Coronary	Artery	
Disease?
Norman Wang, Jason Ng, Indranil Sen-Gupta, Alan H. Kadish, Jeffrey J. Goldberger, 
Northwestern University, Chicago, IL
INTRODUCTION:	 The post-exercise recovery period (PERP), a known period of 
risk for sudden cardiac death (SCD), is characterized by sympathetic withdrawal and 
parasympathetic activation.
METHODS: To evaluate the time course of autonomic change in the PERP, submaximal 
bicycle exercise for 16 minutes was performed by 29 subjects (21 males, mean age 
56 ± 15 years) with coronary artery disease, followed by a 45 minute recovery period. 
Continuous ECG recording was performed to assess the QT interval and heart rate 
variability in the PERP. Plasma norepinephrine (NE) was measured during rest, exercise, 
and recovery.
RESULTS: Heart rate (HR) and plasma NE are shown in the Figure. Compared to rest 
values (shown in graph by dashed line), HR at 45 minutes and plasma NE at 30 minutes 
in the PERP were increased by 8.3% (p = 0.00003) and 37.7% (p = 0.0004), respectively. 
Time dependent changes in QT interval (p < 0.0001) and root mean squared successive 
differences (p < 0.0001) were noted in recovery but had not returned to the baseline value 
even at 45 minutes.
CONCLUSIONS: Persistent sympathetic activation manifested by increased HR and NE 
levels is noted for at least 30-45 minutes in the PERP. This is likely an important factor 
in the increased SCD risk in this time period, and may be the mechanism by which ß-
blockers reduce this risk.
9:45 a.m.
406-8	 Increased	Risk	of	Incident	Stroke	Associated	with	the	
Cyclooxygenase	2	(COX-2)	G-765C	Polymorphism	
in	African-Americans:	The	Atherosclerosis	Risk	in	
Communities	Study
Shun Kohsaka, Kelly A. Volcik, Aaron R. Folsom, Kenneth K. Wu, Christie M. Ballantyne, 
James T. Willerson, Eric Boerwinkle, Texas Heart Institute, Baylor College of Medicine, 
Houston, TX
Background: A hallmark feature of atherosclerosis is inflammation mediated by 
prostaglandins (PGs) catalyzed by the enzyme cyclooxygenase (COX).
The present study explored whether the COX-2 G-765C polymorphism contributes to 
increased incidence of coronary heart disease (CHD) or stroke in the large prospective 
Atherosclerosis Risk in Communities (ARIC) Study.
Methods: Incidences of CHD and stroke were identified through annual follow-up and 
hospital and death certificate surveillance. The study included 1,488 incident CHD and 
527 stroke events after an average of 14 years of follow-up. The frequency of the -765C 
variant allele was markedly different between African-Americans and whites, therefore all 
analyses were performed separately by race. Due to the small number of persons with 
the -765CC genotype, heterozygous and homozygous variant genotypes were combined 
for this analysis.
Results: The COX-2 G-765C polymorphism was a significant predictor of incident stroke 
in African-Americans but it was not a significant predictor of CHD in either racial group. 
After adjustment for age and gender, the hazard rate ratio for developing stroke for the 
CG+CC genotypes relative to the GG genotype was 1.34 (95% confidence interval [CI] 
1.03-1.74, p=0.03) in African-Americans. This result was essentially unchanged when 
established predictors such as smoking, diabetes and hypertension were added to the 
model (HRR 1.34, 95%CI 1.03-1.76, p=0.03).
Conclusion: We have found the COX-2 G-765C polymorphism to be a risk factor for 
incident stroke in African-Americans. This study provides additional evidence for utilizing 
inflammation-related genetic polymorphisms for identifying individuals at increased risk 
for stroke.
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406-5	 Mechanism	Of	Ventricular	Fibrillation	In	The	Aged	
Hearts	Expsoed	To	Glycolytic	Inhibition;	A	New	Model	
Of	Sudden	Cardiac	Death
Norishige Morita, Norihiko Ono, Hideki Hayashi, Masahiro Ogawa, Shien-Fong Lin PhD, 
William J. Mandel, James N. Weiss, Peng-Sheng Chen, Hrayr S. Karagueuzian, the 
Division of Cardiology, Cedars-Sinai Medical Center and the Department of Medicine 
David Geffen, Los Angeles, CA
Background	 and	 Hypothesis: Decrease sarcoplasmic reticulum calcium pump 
(SERCA2a) activity by substrate deprivation, aging or oxidative stress alters intracellular 
calcium ion (Cai2+) cycling and cardiac excitability. We hypothesized that reduced 
SERCA2a activity by glycolytic inhibition (GI) acts synergistically with aging to promote 
ventricular fibrillation (VF).
Methods	 and	 Results: We studied Langendorff-perfused 8 young (2-3 months) and 
14 old (2-3 years) rats. The anterior epicardium of the left ventricle was mapped using 
simultaneous dual voltage- and Cai2-sensitive fluorescent dyes and single cell glass 
microelectrode recordings from selected sites. GI (zero glucose + 10 mM pyruvate) 
promoted VF in 13 of 14 old rats, but in none of the 8 young rats (P<0.05). The onset 
of VF was characterized by a short burst of monomorphic ventricular tachycardia that 
arose from a focal source at the base of the heart and propagated as a single wavefront. 
Within few seconds the tachycardia degenerated into VF with multiple irregular wavelets. 
Microelectrode recordings from the base of the heart showed that the focal tachycardia 
was initiated by an early afterdepolarization (EAD) mediated triggered activity. EADs 
arose from membrane potentials of -45 to -65 mV when the diastolic Cai2+ levels were 
>30% of the peak systolic Cai2+ transient amplitude. The rate constant of Cai2+ transient 
decline τ, was slower at the base (P<0.05) compared to all other sites. During triggered 
activity discordant action potential and Cai2+ transient amplitude alternans emerged 
leading to VF. τ was faster in young than in old rats (98±14 ms vs. 140±20 ms, P<0.01), 
and slightly but significantly rose after GI. Thapsigargin-induced (1-5 µM) increase of τ 
in the young rats to values equal or higher than in old rats failed to promote VF. Old rats 
had significantly greater ventricular interstitial fibrosis and reduced immunodetectable 
SERCA2 (P<0.001).
Conclusions:
GI interacts with the fibrotic aged ventricles to promote EAD-mediated triggered activity, 
which creates spatially discordant repolarization alternans leading to wavebreak and VF.
9:15 a.m.
406-6	 Dissociation	of	Aldehyde	Dehydrogenase	Activity	from	
Nitrate	Effect,	Bioconversion,	and	Tolerance	in	Humans
Andrew C. Philpott, Peter R. Sage, Irene Stafford, Geraldine Murphy, Ivan de la Lande, 
Robert Stuklis, James Edwards, John D. Horowitz, University of Adelaide, Adelaide, 
Australia, Queen Elizabeth Hospital, Adelaide, Australia
Background: Aldehyde dehydrogenase (ALDH) has recently been reported to be the 
principal mediator of nitroglycerin (NTG) bioconversion, and central to the development 
of nitrate tolerance. These conclusions have been largely based on animal experiments 
and require validation in human experimental models.
Methods - Twenty-four patients undergoing elective coronary artery bypass were 
randomised to receive 18 hours of intravenous nitroglycerin (nitrate group, n=12), or no 
nitrate therapy (control group, n=12). Ex vivo segments of saphenous vein (SV) and radial 
artery (RA) were then used to examine (1) vascular responsiveness to NTG, and the 
direct NO donor sodium nitroprusside (SNP), (2) ex vivo bioconversion of NTG to 1,2- and 
1,3-glyceryl dinitrate (SV only); and (3) vascular ALDH activity (SV only).
Results - When comparing the nitrate and control groups, vasorelaxant responses to 
NTG were unchanged in saphenous vein (log EC50’s -6.70 +/- 0.13 vs -6.74 +/- 0.11 for 
nitrate vs control group) and only modestly reduced in radial arteries (log EC50’s -7.12 +/- 
0.03 vs -7.84 +/- 0.06 for nitrate vs control group, p<0.05). No difference in response to 
SNP was found in both saphenous vein and radial artery.
The tissue content of 1,2-glyceryl dinitrate (reflecting ex vivo NTG bioconversion) was not 
significantly different between groups (0.06+/- 0.01 vs 0.08+/- 0.01 pmol/mg for nitrate 
vs control group).
Despite this, the ALDH activity within saphenous veins was markedly depressed in the 
nitrate group compared with the controls (2.0+/- 2.9 in nitrate group vs 17.8+/- 5.3 nmol/
min/mg protein in control group, p<0.001).
Conclusions - Nitroglycerin rapidly and extensively inactivates vascular ALDH: this 
inactivation occurs prior to the development of significant nitrate tolerance, and prior 
to detectable impairment of nitroglycerin bioconversion. Thus ALDH, while possibly 
a contributor, is not the major mediator of nitroglycerin bioconversion or tolerance in 
humans.
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406-9	 Myocardial	Regeneration	Through	Periostin-induced	
Cardiomyocyte	Proliferation
Bernhard Kuhn, Federica del Monte, Roger J. Hajjar, Shima Arab, Mark T. Keating, 
Children’s Hospital Boston, Boston, MA, Massachusetts General Hospital, Boston, MA
Background: Cardiomyocyte proliferation in injured human hearts is not sufficient for 
myocardial regeneration. Unreplaced loss of cardiomyocytes causes heart failure, 
a significant health problem worldwide. Proliferation of differentiated endogenous 
cardiomyocytes may enhance the regenerative capacity of mammalian hearts.
Methods: We screened candidate factors for their potential to induce proliferation of 
differentiated cardiomyocytes in vitro. The in vivo regenerative potential was tested in a 
rat model of myocardial infarction.
Results: Periostin, a component of the extracellular matrix, stimulated DNA synthesis 
and cytokinesis of differentiated rod-shaped cardiomyocytes in vitro. Periostin-stimulated 
cardiomyocyte proliferation required activation of integrins and phosphorylation of ERK1/2 
and Akt. In vivo, myocardial injection of recombinant periostin induced cardiomyocyte 
DNA synthesis and cytokinesis. After experimental myocardial infarction, long-term local 
administration of periostin in rats increased the ejection fraction from 53% after one week 
to 66% after 12 weeks (P=0.0023), whereas in control animals the ejection fraction was 
unchanged (51% to 50%, P=0.6). The number of differentiated cardiomyocytes in S-
phase of the cell cycle was 18-fold higher in rats treated with periostin compared with 
control rats, indicating that periostin induced myocardial regeneration by proliferating 
endogenous cardiomyocytes.
Conclusions: These results indicate that periostin applied locally induces myocardial 
regeneration through proliferation of differentiated endogenous cardiomyocytes. Periostin 
and the pathway it regulates may provide a new target for innovative strategies to treat 
heart failure.
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409-5	 Vasp	Phosphorylation	Analysis	Predicts	Ischemic	
Recurrence	in	Patients	Undergoing	Coronary	
Angioplasty.
Laurent Bonello, Franck Paganelli, Jose Sampol, M. Arpin-Bornet, Paul Barragan, 
Francoise Dignat-George, Laurence Camoin-Jau, Hopital universitaire nord, marseille, 
France, UFR de pharmacie, Inserm U 608, MARSEILLE, France
Background: Biological resistance to clopidogrel may be a potential cause for a part of 
ischemic recurrence after PCI despite use of dual anti aggregant therapy. We analysed 
whether biological response to clopidogrel assessed by the degree of vasodilatator-
stimulated phosphoprotein (VASP) phosphorylation could predict ischemic recurrence 
after percutaneous coronary intervention (PCI).
Method 144 patients with various stage of CAD were prospectively enrolled. Platelet 
reactivity (PR) was evaluated 24 hours after a loading dose of 300 mg of clopidogrel and 
before PCI. All cardiovascular ischemic events were collected on the 6th month including: 
cardiovascular death, stroke, acute coronary syndrome, re-PCI or CABG.
Results: (table 1)Twenty one ischemic recurrence were reported. Receiver’s Operator 
Characteristic Curve of VASP demonstrates an optimal cut off value of 50% PR for 
prediction of ischemic recurrence. Using this cut off of VASP analysis, there is a significant 
difference between the frequency of recurrence between groups of patients. This test 
has a high sensibility (100%) and a low specificity (25%) which is consistent with the 
multifactorial pathophysiology of CAD.
Conclusions: Our study demonstrates that, in CAD patients undergoing PCI, biological 
resistance to clopidogrel, evaluated by VASP analysis, has a high negative predictive 
value for recurrence. Prospective evaluation of individual platelet response to clopidogrel 
before PCI would allow therapeutic optimization. 
11:15 a.m.
409-6	 Kruppel-like	factor	4	(KLF4)	Regulates	Endothelial	
Inflammation
Anne Hamik, Zhiyong Lin, Ajay Kumar, Mercedes Balcells, Sumita Sinha, Jonathan 
Katz, Robert E. Gerzsten, Elazer R. Edelman, Mukesh K. Jain, Brigham and Women’s 
Hospital, Boston, MA
The vascular endothelium plays a critical role in vascular homeostasis. Inflammatory 
cytokines and non-laminar blood flow induce endothelial dysfunction and confer a 
proadhesive and prothrombotic phenotype. Therefore, identification of factors that 
mediate the effects of these stimuli on endothelial function is of considerable interest. 
KLF4 expression has been documented in endothelial cells, however a function has not 
been described. In this communication we describe in detail the expression in vitro and 
in vivo of KLF4 in human and mouse endothelial cells. Furthermore, we demonstrate that 
endothelial KLF4 is induced by pro-inflammatory stimuli and shear stress. Overexpression 
of KLF4 induces expression of multiple anti-inflammatory and anti-thrombotic factors 
including eNOS and thrombomodulin while depletion of KLF4 leads to enhancement of 
TNF-induced VCAM-1 and tissue factor expression. The functional importance of KLF4 
is verified by demonstrating that KLF4 expression markedly decreases inflammatory cell 
adhesion to the endothelial surface and prolongs clotting time under inflammatory states. 
KLF4 differentially regulates the promoter activity of pro- and anti-inflammatory genes in 
a manner consistent with its anti-inflammatory function. These data implicate KLF4 as a 
novel regulator of endothelial activation in response to pro-inflammatory stimuli.
11:30 a.m.
409-7	 Effect	of	Cell	Based	Intercellular	Delivery	of	GATA-4	On	
Ischemic	Cardiomyopathy
Jing Bian, Zoran B. Popovic, Carlos Benejam, Mathew Kiedrowski, Leonardo Rodriguez, 
Marc S. Penn, Cleveland Clinic, Cleveland, OH
Background:Significant alterations in cellular function are possible following the 
introduction of transcription factors. Recent loss-of-function studies highlight the importance 
of the transcription factor GATA4 in the myocardial response to injury in the adult heart. 
However, the importance and therapeutic potential of gain-in-function of GATA-4 over-
expression and transcription factors in general is hindered by the fact that transcription 
factors are neither secreted nor taken up by cells. Chimeric proteins incorporating motifs 
of cell penetrating proteins (CPP) are secreted from cells and internalized by surrounding 
cells potentially making possible the local delivery of transcription factors of interest.
Methods: We engineered a chimeric protein consisting of GATA4 and the CPP VP22. 
Cardiac fibroblasts (CF) stably transfected with the GATA4:VP22, GFP:VP22 or GFP 
constructs were transplanted into Lewis rats 1 month after LAD ligation in order to obtain 
sustained delivery of functional GATA4 to the infarct border zone.
Results: Immunofluorescence demonstrated VP22 chimeric proteins in cardiac myocytes 
surrounding areas of engrafted CF. GATA4:VP22 expression in the border zone was 
associated with increased cardiac myosin expression and cardiac myocyte size (30 μm 
vs. 19 μm, p<0.01). Compared with the GFP:VP22 control group, animals that received 
GATA4:VP22 expressing CF had increased i) shortening fraction (percent change from 
baseline 54% vs. -15%, p<0.05), ii) inferior wall thickening (65% vs. 35%, p<0.05), 
and reduced area of collagen deposition (19% vs. 39%, p<0.01) six weeks after CF 
transplantation (10 weeks after MI).
Conclusions: These data demonstrate a novel strategy for transcription factor delivery 
to injured myocardium and indicate that the delivery of GATA4 locally to the infarct border 
zone induces multiple local effects in the border zone cardiac myocytes resulting in 
beneficial ventricular remodeling and improved global left ventricular function.
11:45 a.m.
409-8	 Tetrahydrobiopterin-dependent	eNOS	Coupling	
Determines	Vascular	Remodeling	Through	Accelerated	
Endothelial	Regeneration
ZIAD A. ALI, Nicholas J. Alp, Yanhua Hu, Qingzhong Xiao, Amy L. Tatham, Jospeh P. 
deBono, Ruth Rinze, Gillian Douglas, Asim M. Akhtar, David R. Greaves, Qingbo Xu, 
Keith M. Channon, University of Oxford, Oxford, United Kingdom, St Georges Hospital 
Medical School, London, United Kingdom
Background: As a result of surgical trauma, ischemia and exposure to arterial pressure 
the majority of endothelial cells in vein grafts undergo necrosis or apoptosis early after 
surgery. Recent evidence suggests that eNOS is essential for mobilization of stem and 
progenitor cells. We hypothesized that eNOS coupling mediates endothelial regeneration 
attenuating accelerated atherosclerosis after vein bypass grafting.
Methods: Transgenic mice with endothelial-targeted overexpression of the essential 
eNOS coupling cofactor BH4 crossed onto ApoE-KO background (GCH/ApoE-KO) or 
their ApoE-KO littermates underwent bypass grafting of donor caval vein to the carotid 
artery. Grafts were constructed in four groups, either as isogenic grafts or in a crossover 
design between genotypes, and harvested 28 days post surgery.
Results: Superoxide production was attenuated 8-fold (P<0.01) in GCH/ApoE-KO mice. 
Inhibition of eNOS by L-NAME reversed these effects, confirming the endothelium as 
the source of superoxide and preserved eNOS coupling. As isogenic grafts, BH4 
augmentation reduced total vessel wall area by 61% (P<0.001) compared to ApoE-KO 
controls. However, when donor veins from ApoE-KO mice were grafted into recipient 
GCH/ApoE-KO mice the reduction in lesion area was maintained (47%, P<0.001), 
indicating a host derived phenotype. Conversely, when GCH/ApoE-KO donor veins were 
grafted into recipient ApoE-KO mice there was no reduction in lesion area compared to 
ApoE-KO controls. In keeping with these findings, transgenic GCH mRNA and vascular 
BH4 levels in ApoE-KO veins grafted into GCH/ApoE-KO recipients reached similar 
levels to GCH/ApoE-KO veins grafted into GCH/ApoE-KO mice, further suggesting host 
derived endothelial repopulation. When grafts were constructed in GCH/ApoE-KO mice 
expressing an endothelial reporter gene (LacZ) using veins from non-LacZ GCH/ApoE-
KO mice, endothelial repopulation was accelerated by 21% (P<0.01) compared to ApoE-
KO veins grafted into ApoE-KO/LacZ recipients.
Conclusions: Availability of BH4 within the endothelium critically modulates the 
response to vascular injury by maintaining eNOS coupling and accelerating endothelial 
regeneration.
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409-9	 Role	Of	Adiponectin	In	The	Development	Of	Chronic	
Heart	Failure
Yasuhiro Izumiya, Rei Shibata, Noriyuki Ouchi, Kenneth Walsh, Boston University 
aSchool of Medicine, Boston, MA
Background: Obesity is a well-established risk factor for chronic heart failure. Despite the 
prevalence of obesity in our population, the molecular mechanism of how obesity affects 
the failing heart is poorly understood. Adiponectin is an adipocyte-derived hormone 
with anti-atherogenic and anti-diabetic properties, which is downregulated in obesity. 
We have shown that adiponectin exerts protective actions on the heart following acute 
myocardial injury. However little is known about the causal relationship of adiponectin to 
the development of chronic pathological cardiac remodeling. Here, we examined the role 
of adiponectin in chronic heart failure after myocardial infarction (MI) with loss- and gain-
of-function genetic manipulations. 
Methods: Myocardial infarction was created in adiponectin-deficient (APN-KO) and wild-
type (WT) mice by the permanent ligation of left anterior descending artery. Cardiac 
parameters were measured by echocardiogram and miller catheter. Angiogenesis was 
determined by capillary density stained with CD31. Apoptotic activity was determined by 
TUNEL-staining. 
Results: APN-KO mice showed exacerbated left ventricular (LV) dilation, myocyte 
hypertrophy and contractile dysfunction compared with WT mice at 4 weeks after MI. 
Impaired LV function in APN-KO mice was coupled to reduced capillary density and 
increased apoptotic activity in the infarct border zone. No difference in infarct size 
was observed between WT and APN-KO mice, indicating that adiponectin depletion 
contributes to adverse cardiac remodeling following permanent ischemia. Administration 
of adenovirus-mediated adiponectin in WT mice resulted in improved LV function, 
decreased hypertrophy, accelerated angiogenesis and diminished myocardial apoptosis 
following MI. 
Conclusions: These data suggest that adiponectin protects against the development 
of chronic heart failure after MI through its ability to suppress cardiac hypertrophy 
and promote pro-angiogenic and pro-survival activities in the heart. Adiponectin could 
represent a novel molecular target for the treatment of obesity-related heart disease. 
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410-5	 Novel	NKX2.5	Mutations	in	sporadic	Cardiac	Septal	
Defects
Neeraj Tatipalli, Sreekanthan Raghavan, Center for Liver Research and Diagnostics, 
Hyderabad, India, Apollo Hospitals, Hyderabad, India
Background: Homeodomain (HD) protein in NKX2.5 is an evolutionary conserved 
transcriptional factor required for cardiac development. Familial mutations in the HD 
of NKX2.5 gene are associated with cardiac abnormalities, but mutations are rare in 
sporadic cases. Mutations in isolated Ventricular Septal Defects (VSD), Atrial Septal 
Defects (ASD) have not been studied in detail.
Methods: 47 consecutive patients with septal defects willing to provide blood sample 
were analyzed. Patients with syndromic features, associated cardiac defects primarily 
conotruncal malformations were excluded. Patients were screened for NKX2.5 HD 
alterations by nested PCR (Polymerase Chain Reaction) and sequencing.
Results: 4 heterozygous mutations (Arg197Gly, Arg197Asn, Arg197Thr, & Gln196Leu) 
predicted to alter the encoded protein in helix 3 of HD were identified in 19 of 47 patients 
(41%). 55% (15 out of 27) of perimembranous VSDs had mutations in the NKX2.5 HD helix 
3. However none of the 9 isolated ASD patients showed any mutations in NKX2.5 HD.
The 4 mutations identified in the cohorts were not present in 38 controls, sequenced for 
2nd exon of NKX2.5 open reading frame.
Conclusions: 1. All mutations altered highly conserved amino acids in helix 3 of HD, 
which are involved in binding of NKX2.5 to target DNA resulting in haploinsufficiency.
2. Majority of patients with VSDs had mutations in the 197th
amino acid while isolated ASDs seldom showed mutations in the HD of NKX2.5.
2:15 p.m.
410-6	 Mechanism	of	Coagulum	Formation	in	Radiofrequency	
Ablation	and	a	Novel	Method	to	Prevent	it
Bernard B. Lim, K.L. Venkatachalam, Arshad Jahangir, Samuel Asirvatham, Mayo Clinic, 
Rochester, MN
Background: Catheter ablation of cardiac arrhythmias is established therapy but 
suffers from thromboembolism-related complications. Evidence suggests these 
originate from coagulum formation on the catheter/ablated surfaces. Coagulum occurs 
from fibrinogen being activated by thrombin to form a fibrin clot. This occurs despite 
therapeutic heparinization. The pathogenesis of coagulum formation is puzzling and 
hitherto unresolved. Here we report on the molecular basis for coagulum formation and 
demonstrate a novel approach to prevent it.
Methods: Using atomic force microscopy, we found that fibrinogen deposited on surfaces 
for 30 minutes underwent conformational changes which result in spontaneous in-vitro 
fibrin clot formation even in the absence of thrombin. Fibrinogen at neutral pH is negatively 
charged. Applying a negative charge to the surface prevented fibrinogen binding and 
reduced surface thrombosis. We immersed ablation catheters that were uncharged, 
negatively charged or positively charged in heparinized blood for 30 minutes. In separate 
experiments, ablation catheters were sutured to the ventricle of a heparinized, excised 
porcine heart. Radiofrequency ablation was then carried out for 5 minutes with either a 
concurrent negative or positive charge or no charge delivered to the catheter tips.
Results: Scanning electron microscopy images of the catheter tips showed the surface 
coverage of fibrin clot of the catheter surface to be 33.8 % for negatively charged catheters 
compared to 84.7 % (p=0.01) for non-charged catheters. There was no significant 
difference in surface coverage of fibrin clot between positively charged catheters (93.8%) 
and non charged catheters (84.7 %, p=ns). In contrast, thick clot surface coverage for 
positively charged catheters was 87.5 % compared to 28.45 % (p=0.03) for non-charged 
catheters and 11.25 % (p=0.03) for negatively charged catheters compared to non-
charged catheters (28.45 %, p=ns).
Conclusions: Our data show that by preventing fibrinogen from binding to surfaces, 
we can prevent coagulum formation during ablation. We predict that this will prevent 
thromboembolism related complications in electrophysiologic ablation procedures.
2:30 p.m.
410-7	 Anticoagulation	after	Anterior	Myocardial	Infarction	and	
the	Risk	of	Stroke
Jacob Allan Udell, Julie T. Wang, Jack V. Tu, Institute for Clinical Evaluative Sciences, 
Sunnybrook Health Sciences Centre, Toronto, ON, Canada, Vancouver Hospital and 
Health Sciences Centre, University of British Columbia, Vancouver, BC, Canada
CONTEXT: Patients who survive anterior myocardial infarction (AMI) are considered at 
increased risk of stroke but anticoagulation for its prevention at discharge is unclear.
METHODS: We performed an observational analysis of prospectively collected data on 
10,383 patients who survived hospitalization for an MI. Patient outcomes were followed 
for 4 years. Risk factors for stroke were assessed by both univariate and multivariate Cox 
proportional-hazards analysis. Warfarin use was determined at discharge from hospital 
and followed for one year. The main outcome measure was ischemic stroke. Secondary 
outcomes included a combination of death from any cause, nonfatal congestive heart 
failure, or ischemic stroke. A combination of hospitalization for gastrointestinal bleed or 
cerebral haemorrhage was considered as a safety outcome.
RESULTS: We identified 2,942 patients who survived hospitalization for an AMI. Of these, 
163 patients (5.5%) experienced a stroke within 4 years, half of which occurred within 
1 year. There was no significant difference in stroke among AMI compared to all other 
MI. The use of warfarin in AMI patients was not associated with a difference in four-year 
stroke outcome.
CONCLUSION: Among patients who survive AMI, there may be no benefit in the use 
of warfarin in preventing ischemic stroke. Prospective cardiovascular trials focussing on 
anti-thrombin therapies should consider this common morbidity as an important efficacy 
outcome. 
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410-8	 Temporary	Cardiac	Resynchronization	Therapy	for	
Post	Operative	CABG	Patients	With	Left	Ventricular	
Dysfunction
Kenneth C. Civello, Jr., Michael McWilliams, David O. Martin, Andrea Natale, Bruce L. 
Wilkoff, The Cleveland Clinic, Cleveland, OH
Background: Coronary artery bypass graft surgery (CABG) in patients with LV dysfunction 
is a high-risk procedure and has historically carried a high mortality. Given the evidence 
that cardiac resynchronization therapy (CRT) can improve postop hemodynamics and 
aid in weaning from extracorporeal circulation it could be a useful tool in the postop 
management. The goal of this study is to determine if postop outcomes are improved with 
the use of temporary CRT in CABG patients.
Methods: This study was a randomized trial comparing CRT to a control group in postop 
CABG patients with LV dysfunction (EF < 35%). Patients randomized to postop CRT 
pacing had an additional temporary epicardial leads placed on the LV. The RA, RV, and 
LV leads were then connected to an external temporary pacemaker.
Results: We randomized 13 patients to the CRT group and 13 patients to the control 
group. There was no difference in baseline demographics except patients in the CRT 
group had a higher FC (2.3 vs 1.3). Time on vasoactive medications in the CRT arm was 
23 ± 14 hours compared to the control group 53 ± 40 hours (p <0.02). The time in the ICU 
decreased from 75 ± 48 hours in the control arm to 44 ± 21 hours in the CRT arm (p< 
0.05). The time on the ventilator in the CRT and control group was 15 ± 10 hours and 31 
± 32 hours (NS), respectively.
Conclusions: With the use of acute CRT in postop CABG patients with LV dysfunction we 
demonstrated a decrease in the time on vasoactive medications and a decrease in the 
time spent in the ICU.
3:00 p.m.
410-9	 External	Prognostic	Validations	and	Comparisons	
of	Age-	and	Gender-Adjusted	Exercise	Capacity	
Predictions
Soo Hyun (Esther) Kim, Hemant Ishwaran, Eugene Blackstone, Michael S. Lauer, 
Cleveland Clinic, Cleveland, OH
Background:	 Several age- and gender-based definitions of fitness exist, but their 
prognostic power and ability to adjust for age-related effects is unclear.
Methods:	We followed (median 5 years) 22,275 patients without known heart disease 
who underwent exercise stress testing. Models for predicted exercise capacity were 
identified by literature search. Sex-specific multivariable proportional hazards models 
were constructed. Validity was assessed by 4 methods: Akaike Information Criterion 
(AIC), right-censored c-index in 100 out-of-bootstrap samples (OOB), Nagelkerke index 
R2 (R2), and calibration error in 100 bootstrap samples.
Results:	There were 646 deaths in 13,098 men, 430 in 9,177 women. All models had 
low calibration error. In men, the Veterans Affairs model (metabolic equivalents (METs) 
= 18 - (0.15*age)) had the highest AIC and R2. In women, the St James Take Heart 
Project model (METs = 14.7 - (0.13*age)) performed best by all methods. In both models, 
there was an age interaction (Figure) whereby predicted exercise capacity was a weaker 
predictor in older subjects (P for interaction <0.001 in men, 0.003 in women). Categorical 
definitions of fitness performed worst in both genders.
Conclusions:	Published definitions of exercise capacity differ in their ability to predict 
mortality. Simple cut-off values fail to fully describe exercise capacity’s strong predictive 
value. No existing model fully accounts for weaker associations of differences in exercise 
capacity and death in older adults.
